Jazz Pharmaceuticals Plc (JAZZ)
235.67
+2.66
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
235.53
-0.14
(-0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Price : 235.67 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 233.40 | 237.77 | 231.70 | 235.67 | 636627.0 |
| Oct 01, 2026 | 230.33 | 234.47 | 229.85 | 233.01 | 740577.0 |
| Sep 30, 2026 | 231.60 | 236.00 | 230.39 | 231.52 | 1.002M |
| Sep 29, 2026 | 236.30 | 238.00 | 229.16 | 232.35 | 777839.0 |
| Sep 28, 2026 | 235.67 | 238.82 | 234.63 | 238.28 | 788284.0 |
| Sep 25, 2026 | 239.12 | 239.12 | 235.66 | 237.95 | 1.130M |
| Sep 24, 2026 | 235.82 | 236.52 | 232.00 | 236.28 | 551319.0 |
| Sep 23, 2026 | 239.26 | 241.32 | 231.59 | 234.88 | 792218.0 |
| Sep 22, 2026 | 242.01 | 243.20 | 239.78 | 240.57 | 482010.0 |
| Sep 21, 2026 | 240.87 | 244.48 | 238.53 | 241.46 | 499163.0 |
| Sep 18, 2026 | 244.55 | 244.55 | 238.98 | 240.74 | 2.215M |
| Sep 17, 2026 | 246.59 | 247.31 | 243.57 | 243.84 | 569597.0 |
| Sep 16, 2026 | 242.93 | 244.36 | 241.76 | 243.59 | 602267.0 |
| Sep 15, 2026 | 246.81 | 246.81 | 239.84 | 240.83 | 702584.0 |
| Sep 14, 2026 | 247.68 | 248.44 | 244.66 | 245.87 | 465465.0 |
| Sep 11, 2026 | 244.60 | 246.73 | 244.04 | 245.80 | 422911.0 |
| Sep 10, 2026 | 240.94 | 244.46 | 239.28 | 240.48 | 1.029M |
| Sep 09, 2026 | 238.38 | 241.44 | 236.00 | 241.31 | 424473.0 |
| Sep 08, 2026 | 240.00 | 244.71 | 239.11 | 240.07 | 467907.0 |
| Sep 04, 2026 | 246.00 | 249.00 | 244.74 | 246.81 | 321870.0 |
| Sep 03, 2026 | 246.92 | 248.91 | 241.86 | 247.56 | 507617.0 |
| Sep 02, 2026 | 244.00 | 248.07 | 241.02 | 245.57 | 1.156M |
| Sep 01, 2026 | 250.13 | 252.50 | 243.02 | 243.71 | 1.073M |
| Aug 31, 2026 | 241.39 | 252.72 | 241.39 | 250.68 | 1.221M |
| Aug 28, 2026 | 249.48 | 250.64 | 244.49 | 244.54 | 1.193M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Avadel Pharmaceuticals Plc | 21.64 |
| GH Research Plc | 22.94 |
| Cosmo NV | 63.10 |
| Axsome Therapeutics, Inc. | 179.25 |
| Eli Lilly & Co. | 1142.85 |
Price Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 3.336 |
| Price to Book Value | 3.180 |
| Price to Free Cash Flow | 10.18 |
| Earnings Yield | 6.15% |
| Market Cap | 15.27B |
| Operating PE Ratio | 16.07 |
| Normalized PE Ratio | 14.15 |